Volitionrx (VNRX) Capital Expenditures Growth (1y) (2012 - 2025)
Volitionrx (VNRX) Capital Expenditures Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | -47.73% |
| 10 | Volitionrx | 92,985.39 | -1.02 Mn | - | -84.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -84.89% |
| Jun 30, 2025 | 322.79% |
| Mar 31, 2025 | -96.38% |
| Sep 30, 2024 | 127.24% |
| Jun 30, 2024 | -96.38% |
| Sep 30, 2023 | -254.23% |
| Jun 30, 2023 | -7.26% |
| Dec 31, 2022 | 350.14% |
| Sep 30, 2022 | 129.53% |
| Jun 30, 2022 | 146.90% |
| Mar 31, 2022 | -74.24% |
| Dec 31, 2021 | -89.81% |
| Sep 30, 2021 | 72.06% |
| Jun 30, 2021 | -76.38% |
| Mar 31, 2021 | 246.34% |
| Dec 31, 2020 | 931.08% |
| Sep 30, 2020 | 167.18% |
| Jun 30, 2020 | 844.06% |
| Mar 31, 2020 | -194.99% |
| Dec 31, 2019 | -28.33% |